TransMedics (TMDX) Income from Continuing Operations (2018 - 2026)

TransMedics has reported Income from Continuing Operations for 9 years, with the latest figure at $14.7 million in Q2 2026.

• On a quarterly basis, Income from Continuing Operations fell 57.91% year-over-year to $14.7 million in Q2 2026; TTM through Jun 2026 was $171.2 million, a 138.99% increase from a year earlier, with the FY2025 full-year figure at $190.3 million, up 436.66% from the prior year.
• Income from Continuing Operations was $14.7 million for Q2 2026 at TransMedics, up from $7.3 million in the prior quarter.
• The five-year high for Income from Continuing Operations was $124.9 million in Q4 2025, with the low at -$25.4 million in Q3 2023.
• Average Income from Continuing Operations over 5 years is $11.4 million, with a median of $5.5 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations slumped 242.34% in 2023, then soared 1717.74% in 2025.
• Over 5 years, Income from Continuing Operations stood at -$7.0 million in 2022, then surged by 152.56% to $3.7 million in 2023, then surged by 87.58% to $6.9 million in 2024, then jumped by 1717.74% to $124.9 million in 2025, then plunged by 88.25% to $14.7 million in 2026.
• The last three Income from Continuing Operations figures came in at $14.7 million (Q2 2026), $7.3 million (Q1 2026), and $124.9 million (Q4 2025), per Business Quant data.